Why questions are being raised on Russia's corona vaccine Sputnik-V, why the world is not convinced

The coronavirus is the first worldwide vaccine to be released around 9 months after the global pandemic. Russia claims to have created a corona vaccine, named Sputnik-V, and has also received approval for its use. Russian President Vladimir Putin announced on Tuesday about the vaccine. But the world is watching this claim of Russia with skeptical eyes. Because the trial of the third phase of this vaccine is not yet complete, and the results of the second phase have not been made public so far. Therefore, questions are being raised all over the world.

Russia's President Vladimir Putin announced on Tuesday (August 11) that his country had developed the first vaccine against the coronavirus that works 'very effectively' in combating covid-19 and 'a permanent disease-resistant' Builds capacity '. With this, he revealed that one of his daughters had already been given this vaccine.

Doubts from WHO to America

The vaccine is produced under the joint aegis of the Gamalaya Research Institute and the Ministry of Defense of Russia. The clinical trial of the vaccine has been approved for use on common citizens without completion, due to which questions are raised about its safety and effectiveness. Many countries, including the United States, Britain, believe that the way the vaccine trial process is done, Russia is claiming the accuracy of the vaccine before it is completed, which is wrong. While the WHO warned about Russia's hastiness of the Corona vaccine last week, top health expert Anthony Fossey of the US has raised doubts over the vaccine for both Russia and China to follow the correct procedure.

How does this vaccine work

Indeed, this Sputnik-5 vaccine from Russia is based on the DNA of a SARS-CoV-2 type of adenovirus, a common cold virus. This corona vaccine divides a viral into small pieces and uses small viruses for this. After which it increases immunity. Speaking to Sputnik News, Alexander Gintzberg, director of the Gamalaya National Research Center, said that the coronavirus particles in the vaccine cannot harm the body because their numbers do not increase.

Only the first phase results are public

Russia has so far made public the results of the Phase I clinical trial of the Corona vaccine, claiming that the first phase of the vaccine trial has been successful. In mid-July, Russia's TASS News Agency said that the Ministry of Defense claimed that no volunteers had seen any side effects after the trial.

First phase trial on 76 jawans

Russia did this test on 76 army personnel in the first phase of the vaccine. Half of these people were given vaccine doses in a liquid form and half were given soluble powders.

So the questions are arising

According to the news report, the second phase of the vaccine trial began on 13 July, and on 3 August the Russian media reported that the Gamalaya Research Institute had completed the clinical trial of the vaccine. However, it was not clear in these reports whether only the second phase was completed or all the three phases were completed. The second phase only takes a few months.

It is also special that Russia had earlier indicated that the third phase of human trials will be completed only after getting permission from the regulator. In this phase, thousands of people are tested.

These companies were ahead in the race, but…

Many questions are being raised about the speed with which Russia has developed the vaccine. Companies such as Oxford-AstraZeneca, Moderna and Fiji were ahead in the race to make the Corona vaccine, but Russia's sudden claim to produce the vaccine has surprised everyone and raised doubts. Experts believe that the Russian government is putting people's lives in danger due to the early launch of the Corona vaccine.

According to the report of the news agency AP, Russia will start industrial production of the vaccine on a large scale from September and from October it will be available to the general public. Large scale hinges will start from October.